Global Structural Heart Devices Market Expected to Grow with a CAGR of 12.08% During the Forecast Period, 2019-2024 - ResearchAndMarkets.com

DUBLIN--()--The "Structural Heart Devices Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.

The structural heart devices market is expected to grow at a CAGR of 12.08% to achieve a market size of USD8.918 billion in 2024.

Structural heart disease is referred to a defect or an abnormality in the heart structure which in later life of an individual may interfere with the normal heart functioning. Hence, this needs to be rectified as soon as detected, driving market growth in the forecast period. Thus, the prevalence of structural heart diseases is one of the major drivers driving the growth of the global structural heart devices market. Additionally, regulatory approvals for advanced structural heart devices and growing awareness regarding the structural heart diseases are further driving the market growth worldwide in the forecast period and in the coming years.

Geographically, the North American region is expected to hold a significant market share due to the highest health expenditure of the United States among all the industrialized regions of the world followed by the Asia Pacific region, which is expected to be the fastest-growing. Furthermore, the growing adoption of minimally invasive procedures are further providing an opportunity for the market to thrive in the upcoming years

The Structural Heart Devices Market - Forecasts from 2019 to 2024 is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, component, platform, and geography.

Major players in the structural heart devices market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the structural heart devices market.

Key Topics Covered:

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter's Five Forces Analysis

4.5.1. Bargaining Power of Suppliers

4.5.2. Bargaining Power of Buyers

4.5.3. Threat of New Entrants

4.5.4. Threat of Substitutes

4.5.5. Competitive Rivalry in the Industry

4.6. Life Cycle Analysis- Regional Snapshot

4.7. Market Attractiveness

5. STRUCTURAL HEART DEVICES MARKET BY PRODUCT TYPE

5.1. Heart Valve Devices

5.2. Occluders

5.1.1. PFO Occluders

5.1.2. ASD Occluders

5.1.3. VSD Occluders

5.1.4. LAA Occluders

6. STRUCTURAL HEART DEVICES MARKET BY PROCEDURE

6.1. Cardiac Catheterization/Minimally Invasive

6.2. Open Heart Surgery

7. STRUCTURAL HEART DEVICES MARKET BY GEOGRAPHY

7.1. North America

7.2. South America

7.3. Europe

7.4. Middle East and Africa

7.5. Asia Pacific

8. COMPETITIVE INTELLIGENCE

8.1. Competitive Benchmarking and Analysis

8.2. Recent Investments and Deals

8.3. Strategies of Key Players

9. COMPANY PROFILES

11.1. Edwards Lifesciences Corporation

11.2. Medtronic

11.3. Abbott

11.4. Boston Scientific Corporation or its affiliates

11.5. LivaNova PLC

11.6. CryoLife, Inc.

11.7. Micro Interventional Devices, Inc.

11.8. Braile Biomdica

11.9. TTK Healthcare Limited

11.10. Lepu Medical Technology (Beijing) Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/rw34e6

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900